References

Alperin M, Burnett L, Lukacz E, Brubaker L. The mysteries of menopause and urogynecologic health: clinical and scientific gaps. Menopause. 2019; 26:(1)103-111 https://doi.org/10.1097/GME.0000000000001209

Ellsworth P, Marschall-Kehrel D, King S, Lukacz E. Bladder health across the life course. Int J Clin Pract. 2013; 67:(5)397-406 https://doi.org/10.1111/ijcp.12127

Gandhi J, Chen A, Dagur G Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol.. 2016; 215:(6)704-711 https://doi.org/10.1016/j.ajog.2016.07.045

Hum M, Dytoc M. A dermatologist's approach to genitourinary syndrome of menopause. J Cutan Med Surg. 2017; 21:(5)418-424 https://doi.org/10.1177/1203475417708165

Lester J, Pahouja G, Andersen B, Lustberg M. Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med. 2015; 5:(2)50-66 https://doi.org/10.3390/jpm5020050

Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA)—results from an international survey. Climacteric. 2012; 15:(1)36-44 https://doi.org/10.3109/13697137.2011.647840

Portman DJ, Gass ML Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 21:(10)2014-1068 https://doi.org/ 10.1097/GME.0000000000000329

Sassarini J, Lumsden MA. Oestrogen replacement in postmenopausal women. Age Ageing. 2015; 44:(4)551-558 https://doi.org/10.1093/ageing/afv069

Sousa M, Peate M, Jarvis S, Hickey M, Friedlander M. A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Ther Adv Med Oncol.. 2017; 9:(4)269-285 https://doi.org/10.1177/1758834016687260

Williams NO, Lustberg MB. Time for action: managing genitourinary syndrome of menopause. J Oncol Pract. 2019; 15:(7) https://doi.org/10.1200/JOP.19.00350

The impact of genitourinary syndrome of menopause on continence

26 March 2020
Volume 29 · Issue 6

Most women approaching the menopause are only too aware of the possibility that they can look forward to mood swings, hot flushes, night sweats and reduced libido (Sassarini and Lumsden, 2015). What is not always so commonly appreciated is the effect of the hormonal changes on the woman's urogenital tract.

Oestrogen receptors are found in abundance in the urethra and urinary bladder, vagina and structures of the pelvic floor (Alperin et al, 2019). As the woman's oestrogen levels decline, the epithelial cells of the vagina also degenerate, with the loss of elastin, collagen and subcutaneous fat, all of which affect the integrity and robustness of the vulvovaginal tissues. Objectively, the woman may experience dryness, irritation and skin tightness in and around the vagina. In years gone by this phenomenon was known as ‘atrophic vaginitis’. The term described the external physiological signs of oestrogen deficit, but failed to effectively articulate the full spectrum of genitourinary symptoms that evidence now shows are concomitant with menopause.

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content